Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053320 · ClinicalTrials.gov registry record · NA
Spatial-Motor Stroke-Rehab Study
A NA study of Stroke and Spatial Neglect, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 3
- Study locations
NCT06053320: Recruiting NA study of Stroke and Spatial Neglect, sponsored by Emory University.
NCT06053320 is a NA study of Stroke and Spatial Neglect that is actively recruiting participants, run by Emory University. The registered enrollment target is 65 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053320, a NA study of Stroke and Spatial Neglect, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to understand how prism adaptation training with and without electrical stimulation changes visuospatial behavior, motor system neurophysiology, and walking dysfunction.
Primary Outcome
Measured by the neuropsychological laboratory pointing behavior with the Kessler Foundation Neglect Assessment Process (KF-NAP) tool. Patients are asked to point with their eyes closed towards the center (proprioceptive pointing) and eyes open towards a target (visuo-proprioceptive pointing) on a standing calibrated board unaffected hand). The test is scored by measuring the deviation from 0 (midline). Pre-PAT and post-PAT measures are compared, there is no minimum or maximum score. A more negat
Conditions Studied
Interventions
- OTHER Gait Training
- DEVICE Prism adaptation therapy (PAT) + Electrical stimulation (E-stim)
- DEVICE Prism adaptation therapy (PAT) + Sham Stimulator
Study Locations (3)
Georgia
- Emory Rehabilitation Hospital - Atlanta
- Emory University Hospital (EUH) - Atlanta
- Executive Park - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2023-04-11 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT06053320 shows while recruiting
NCT06053320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Gait Training is the first listed.
NCT06053320 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06053320 about?
NCT06053320 is a clinical study titled "Spatial-Motor Stroke-Rehab Study". The purpose of this study is to understand how prism adaptation training with and without electrical stimulation changes visuospatial behavior, motor system neurophysiology, and walking dysfunction.
What is the current status of trial NCT06053320?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2023-04-11. Estimated completion is 2026-03.
What conditions does trial NCT06053320 study?
This clinical trial studies the following conditions: Stroke, Spatial Neglect.
What interventions are being tested in trial NCT06053320?
The interventions under investigation include: Gait Training (OTHER), Prism adaptation therapy (PAT) + Electrical stimulation (E-stim) (DEVICE), Prism adaptation therapy (PAT) + Sham Stimulator (DEVICE).
Who is sponsoring clinical trial NCT06053320?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053320 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06053320's enrollment target sits among peer trials
65 195th of 454 higher than 258 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI